Medicure, Inc. (NASDAQ:MCUJF) | WebDisclosure

Basculer en Français

10719	Companies
229677	Keywords
158200	Articles
121980	Press releases

Home
Companies
Medicure, Inc.

PRESS RELEASE

published on 11/18/2024 at 23:00, 1 year 7 months ago

Medicure to Present Financial Results on November 26, 2024 Call at 8:30 AM ET for Quarter Ended September 30, 2024 and Announces Resignation of Board Member
Medicure Inc. announces 2024 Q3 Financial Results conference call on November 26, 2024. Board member resigns. Company specializes in pharmaceuticals & healthcare products

Conference Call Pharmaceuticals Medicure Inc. Healthcare Products 2024 Q3 Financial Results
BRIEF

published on 10/25/2024 at 00:05, 1 year 8 months ago

Medicure Reaches Settlement in Product Development and Supply Contract

Pharmaceuticals Product Development Healthcare Products Medicure Settlement
BRIEF

published on 10/25/2024 at 00:05, 1 year 8 months ago

Medicure parvient à un accord sur le développement et la fourniture de produits

Médicaments Développement De Produits Produits De Santé Medicure Règlement
PRESS RELEASE

published on 10/25/2024 at 00:00, 1 year 8 months ago

Medicure Announces Positive Settlement of Product Development and Supply Contracts
Medicure Inc. settles a product development and supply contract with a third party, receiving €1.5 million. Details remain confidential. Company focuses on pharmaceuticals and healthcare products in the U.S. market

Pharmaceuticals Medicure Inc. Product Development Healthcare Products Supply Contract
BRIEF

published on 08/14/2024 at 23:35, 1 year 11 months ago

Medicure finalise l'acquisition de la propriété intellectuelle de CanAm Bioresearch

Propriété Intellectuelle Acquisition De MediCure Recherche Biologique CanAm Développement Thérapeutique Actifs Pharmaceutiques
BRIEF

published on 08/14/2024 at 23:35, 1 year 11 months ago

Medicure Completes Acquisition of Intellectual Property from CanAm Bioresearch

Intellectual Property CanAm Bioresearch Medicure Acquisition Therapeutic Development Pharmaceutical Assets
PRESS RELEASE

published on 08/14/2024 at 23:30, 1 year 11 months ago

Medicure Announces Closing of Asset Purchase Agreement with Canam Bioresearch for Acquisition of Intellectual Property
Medicure Inc. acquires intellectual property assets of CanAm Bioresearch Inc. related to new chemical entities for therapeutic use. Agreement terms and related party transaction details provided

Medicure Inc. New Chemical Entities Therapeutic Use CanAm Bioresearch Inc. Intellectual Property Assets
BRIEF

published on 08/14/2024 at 23:05, 1 year 11 months ago

Medicure publie ses résultats financiers pour le trimestre clos le 30 juin 2024

Résultats Financiers Medicure AGGRASTAT ZYPITAMAG Drogue Marley
BRIEF

published on 08/14/2024 at 23:05, 1 year 11 months ago

Medicure Reports Financial Results for Quarter Ended June 30, 2024

Financial Results Marley Drug Medicure AGGRASTAT ZYPITAMAG
PRESS RELEASE

published on 08/14/2024 at 23:00, 1 year 11 months ago

Medicure Reports Financial Results for Quarter Ended June 30, 2024
Medicure Inc. reports Q2 2024 financial results: net revenue down, EBITDA negative, net loss recorded. AGGRASTAT and ZYPITAMAG sales impacted. Analyst call on Aug 15, 2024

Financial Results EBITDA Medicure Inc. Net Loss Q2 2024

Accesswire

Published on 07/14/2026 at 22:30, 1 hour 12 minutes ago

Hillcrest Energy Technologies Announces Board and Leadership Changes Following 2026 Annual General Meeting
Published on 07/14/2026 at 22:30, 1 hour 12 minutes ago

Loop Industries Reports First Quarter Fiscal 2027 Results and Provides Update on Progress Towards Commercialization
Published on 07/14/2026 at 16:40, 7 hours 2 minutes ago

AIAI Holdings' MediGuide Enters the State-of-the-Art Medicine Market With AI-Driven Innovation
Published on 07/14/2026 at 15:45, 7 hours 57 minutes ago

Silver Storm Commences Hot Commissioning of the La Parrilla Sulphide Circuit, Amends the Samsung Prepayment Agreement, and Secures US$5 Million Loan from First Majestic
Published on 07/14/2026 at 15:15, 8 hours 27 minutes ago

Gratomic Inc. Provides Corporate Update for Shareholders

View all ACCESSWIRE

EQS Group

Published on 07/14/2026 at 19:14, 4 hours 28 minutes ago

EQS-Adhoc: Nagarro SE: BaFin Enforcement Review of the 2022 Consolidated Financial Statements
Published on 07/14/2026 at 18:17, 5 hours 24 minutes ago

EQS-Adhoc: Delivery Hero confirms advanced negotiations with Uber Technologies in respect to potential takeover offer
Published on 07/14/2026 at 17:51, 5 hours 50 minutes ago

Aumann announces share buyback with an allotment ratio of approximately 6%
Published on 07/14/2026 at 17:30, 6 hours 11 minutes ago

NABR: The U.S. Fish and Wildlife Service for the Second Time Rejects Activists' Petition to List Long-Tailed Macaque Monkeys Under the Endangered Species Act
Published on 07/14/2026 at 17:28, 6 hours 14 minutes ago

Turkiye Garanti Bankasi A.S.: CMB Approval for Bond Issuance to Foreign Markets

Les Echos

Published on 07/13/2026 at 18:00, 1 day 5 hours ago

CP Icade - Icade reprend 100% de la propriété de la Tour Eqho à la Défense
Published on 07/13/2026 at 18:00, 1 day 5 hours ago

PR Icade - Icade regains full ownership of the Eqho Tower in La Défense
Published on 07/13/2026 at 18:00, 1 day 5 hours ago

THERMADOR GROUPE : 2026 half-year turnover
Published on 07/13/2026 at 18:00, 1 day 5 hours ago

THERMADOR GROUPE : publication du chiffre d'affaires semestriel 2026
Published on 07/13/2026 at 17:45, 1 day 5 hours ago

Weekly share buyback

View all LES ECHOS COMFI WIRE